Best Practice Outcomes for Schizophrenia: Does Measurement of Medication Compliance Provide a Key?

American Psychiatric Association. Practice guidelines for the treatment of patients with schizophrenia. American Journal of Psychiatry 1997:154(Suppl.): 1–63.

APA Practice Guidelines. 1997.

Barimi C Saraceno B Liberati A Garattini S Low dose neuroleptic therapy and relapse in schizophrenia: meta analysis of randomized controlled trials. European Psychiatry 1993;11:306–313.

Fleischhhaker WW MUGVK: Compliance with antipsychotic drug treatment: influence of side effects. Acta Psychiatrica Scand. 1994;89(Suppl. 382): 11–15.

Gilbert PL Harris MJ McAdams LA Jeste DV Neuroleptic withdrawal in schizophrenic patients. A Review of the literature. Archives of General Psychiatry 1995;52:173. 188.

Hogan TP Awad AG Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychological Medicine 1983;13:177–183.

Knapp M. Costs of schizophrenia. British Journal of Psychiatry 1997;171:509–518.

Lehman AF Steinwachs DM At Issue: translating research into practice: the schizophrenia Patient Outcomes Research Team [PORT) treatment recommendations. Schizophrenia Bulletin 1998;24:1–10.

Mari JJ Streiner D. Family intervention reduces relapse rates, rehospitalisation, and costs and increases compliance with medication in schizophrenia. The Cochrane Database of Systematic Reviews 3, 1996.

McFarlane W Link B Dushay R Marchal J Crilly J. Psychoeducational Multiple Family groups: Four-Year Relapse Outcome in Schizophrenia. Family Process 1995;43:127–144.

Meltzer HY Neuroleptic withdrawal in schizophrenic patients. An idea whose time has come. Archives of General Psychiatry 1995;52:200–202.

Morgenstern H Glazer WM Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medication. Archives of General Psychiatry 1993;50:723–733.

Olofson M. Assertive community treatment: an evaluation of the experimental evidence. Hospital and Community Psychiatry 1990;41:635–639.

Rund BR Moe L Sollien T. Fjell A Borchgrevink T Hallert M Naess PO The Psychosis Project: Outcome and cost-effectiveness of a psychoeducational treatment programme for schizophrenic adolescents. Acta Psychiatrica Scandinavica 1994;89:211–218.

Rupp A. The costs of schizophrenia. Psychiatric Clinics of North America 1993;16:413–423.

Solomon P. Moving from psychoeducation to family education for families of adults with serious mental illness. Psychiatric Services 1996;47:1364–1377.

Stein LI Test MA Alternative to mental hospital treatment I. Conceptual model, treatment program and clinical evaluation. Archives of General Psychiatry 1980;37:392–397.

Thompson K Sergejew A Kulkarni J. An improved psychoactive medication compliance questionnaire for use with psychiatric patients. Abstract, 5th Australian Schizophrenia Conference, 1998.

Weiden PJ Olfson M. Cost of relapse in schizophrenia. Schizophrenia Bulletin 1995;21:3.